These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2797493)

  • 1. [Assessment of CEA values in patients with malignant neoplasms].
    Alkilani M; Straci S; Panuccio V
    Minerva Med; 1989 Aug; 80(8):923-5. PubMed ID: 2797493
    [No Abstract]   [Full Text] [Related]  

  • 2. [The tumor markers TPA and CEA in the after care of breast cancer].
    Beaufort F; Fueger GF; Steiner H
    Wien Med Wochenschr; 1985 Feb; 135(4):85-8. PubMed ID: 2986366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical value of CEA studies in patients with benign and malignant breast diseases with special reference to oncologic after care].
    Kunze M; Voss P; Büttner HH; Stranz G; Strache RR
    Zentralbl Gynakol; 1987; 109(24):1517-26. PubMed ID: 3442160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Key role of the CEA test in the diagnosis and surgical therapy of recurrent colorectal cancer].
    Quentmeier A; Schlag P; Herfarth C
    Chirurg; 1986 Feb; 57(2):83-7. PubMed ID: 3698741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CEA (carcinoembryonic antigen) in breast cancer. Clinical value].
    Villani C
    Minerva Med; 1981 Dec; 72(49):3315-22. PubMed ID: 7312207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of tumor markers in colorectal cancer].
    Peters KM; Grundmann R
    Leber Magen Darm; 1989 Jan; 19(1):18-25. PubMed ID: 2927234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
    Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of CEA levels and positive cytology in peritoneal washings in patients with colorectal cancer.
    Kanellos I; Zacharakis E; Kanellos D; Pramateftakis MG; Betsis D
    Colorectal Dis; 2006 Jun; 8(5):436-40. PubMed ID: 16684089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small rise in CEA is sensitive for recurrence after surgery for colorectal cancer.
    Irvine T; Scott M; Clark CI
    Colorectal Dis; 2007 Jul; 9(6):527-31. PubMed ID: 17573747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
    Wichmann MW; Lau-Werner U; Müller C; Hornung HM; Stieber P; Schildberg FW;
    Anticancer Res; 2000; 20(6D):4953-5. PubMed ID: 11326645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoguided surgery in recurrent colorectal cancer: the role of carcinoembryonic antigen, computerized tomography, and physical examination.
    Sardi A; Agnone CM; Nieroda CA; Mojzisik C; Hinkle G; Ferrara P; Farrar WB; Bolton J; Thurston MO; Martin EW
    South Med J; 1989 Oct; 82(10):1235-44. PubMed ID: 2799440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].
    Grotowski M
    Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slope analysis of CA19-9 and CEA for predicting recurrence in colorectal cancer patients.
    Nakayama T; Watanabe M; Teramoto T; Kitajima M
    Anticancer Res; 1997; 17(2B):1379-82. PubMed ID: 9137502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.
    Holubec L; Topolcan O; Pikner R; Pecen L; Vaclavickova J; Wirthova M; Molacek J; Stieber P; Holdenrieder S; Sen LH; Finek J
    Anticancer Res; 2000; 20(6D):5237-44. PubMed ID: 11326702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [After care in colorectal cancer].
    Brunner H
    Wien Med Wochenschr; 1988 Jun; 138(11-12):261-3. PubMed ID: 3176505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid genetic diagnosis with transcription-reverse transcription concerted reaction system for peritoneal recurrence and survival in colorectal cancer patients.
    Hayama T; Iinuma H; Watanabe T
    Oncol Rep; 2007 Oct; 18(4):779-84. PubMed ID: 17786336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen fraction in digestive cancer.
    Fong S; García Vega G; León V
    Neoplasma; 1985; 32(2):199-208. PubMed ID: 4000309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of single and serial CEA determinations with the clinical evolution of cancer patients.
    de Levin RW; Levin E
    Arch Geschwulstforsch; 1982; 52(2):105-12. PubMed ID: 7103688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of carcinoembryonic antigen in colorectal malignancy.
    Mazumdar A; Verma GR; Bose SM; Ganguly NK
    Trop Gastroenterol; 1999; 20(3):107-10. PubMed ID: 10695415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.